SCHEMBL2004433

SCHEMBL2004433

N#Cc1cc(N)n(-c2ncc(C(F)(F)F)cc2Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
ATM Q13315 1/20 0.43
GABRP O00591 4/20 0.43
GABRD O14764 4/20 0.43
GABRA1 P14867 4/20 0.43
GABRB1 P18505 4/20 0.43
GABRG2 P18507 4/20 0.43
GABRB3 P28472 4/20 0.43
GABRA5 P31644 4/20 0.43
GABRA3 P34903 4/20 0.43
GABRA2 P47869 4/20 0.43
GABRB2 P47870 4/20 0.43
GABRA4 P48169 4/20 0.43
GABRE P78334 4/20 0.43
GABRA6 Q16445 4/20 0.43
GABRG1 Q8N1C3 4/20 0.43
GABRG3 Q99928 4/20 0.43
GABRQ Q9UN88 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239495 0.82 GABRB3 (0.60) GABRPGABRDGABRA1GABRB1GABRG2
Ammonia Solution, Strong SCHEMBL8425567 0.81 GABRB3 (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7814766 0.80 GAA (0.52) L3MBTL1POLBGAAATMGABRP
SCHEMBL14615157 0.78 GABRB3 (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2837550 0.78 GABRA2 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2835184 0.78 GABRA2 (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6475236 0.77 KDM4E (0.49) L3MBTL1POLBGAAATMGABRP
SCHEMBL7028502 0.77 GABRB3 (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30693085 0.77 GABRB3 (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6965080 0.77 GABRP (0.47) L3MBTL1POLBGAAATMGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084486-B2 Substituted arylpyrazoles PFIZER LIMITED (GB) 2011-12-27 US disclosed
US-20110196011-A1 SUBSTITUTED ARYLPYRAZOLES PFIZER LIMITED (GB) 2011-08-11 US disclosed
US-7960426-B2 Substituted arylpyrazoles PFIZER LIMITED (GB) 2011-06-14 US disclosed
US-7902232-B2 Substituted arylpyrazoles PFIZER LIMITED (GB) 2011-03-08 US disclosed
US-20090312371-A1 SUBSTITUTED ARYLPYRAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-20090137524-A1 SUBSTITUTED ARYLPYRAZOLES ZOETIS SERVICES LLC 2009-05-28 US disclosed
US-7514464-B2 Substituted arylpyrazoles PFIZER LIMITED (GB) 2009-04-07 US disclosed
EP-1705989-B8 SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS PFIZER LTD (GB) 2009-03-25 EP disclosed
EP-1705989-B1 SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS PFIZER LTD (GB) 2008-11-12 EP disclosed
US-7435753-B2 Substituted arylpyrazoles PFIZER LIMITED (GB) 2008-10-14 US disclosed
EP-0933363-B1 Parasiticidal pyrazoles PFIZER LTD (GB) 2003-08-27 EP disclosed
EP-0946515-B1 PARASITICIDAL PYRAZOLES PFIZER LTD (GB) 2003-03-05 EP disclosed
US-20020173662-A1 Parasiticidal pyrazoles BANKS BERNARD JOSEPH (GB) 2002-11-21 US disclosed
US-6268509-B1 PESTICIDES PFIZER INC 2001-07-31 US disclosed
US-6090394-A FOR HUMANS, ANIMALS PFIZER INC. (US) 2000-07-18 US disclosed
US-6075043-A Parasiticidal pyrazoles PFIZER INC. (US) 2000-06-13 US disclosed
US-6019986-A Parasiticidal pyrazoles PFIZER INC. (US) 2000-02-01 US disclosed
EP-0946515-A1 PARASITICIDAL PYRAZOLES Pfizer Limited (GB) 1999-10-06 EP disclosed
EP-0933363-A1 Parasiticidal pyrazoles Pfizer Limited (GB) 1999-08-04 EP disclosed
WO-1998024767-A1 PARASITICIDAL PYRAZOLES PFIZER LIMITED (GB) 1998-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137524-A1 SUBSTITUTED ARYLPYRAZOLES CYP4X1, EPX, CYP2C9 L3MBTL1 1016/4885POLB 3174/4885GAA 1424/4885
US-20110196011-A1 SUBSTITUTED ARYLPYRAZOLES CYP4X1, EPX, CYP2C9 L3MBTL1 1016/4885POLB 3174/4885GAA 1424/4885
US-20020173662-A1 Parasiticidal pyrazoles HRH3, HRH2, HRH1 L3MBTL1 953/4885POLB 4325/4885GAA 3178/4885
US-20090312371-A1 SUBSTITUTED ARYLPYRAZOLES CYP3A43, CYP3A4, CYP4X1 L3MBTL1 1465/4885POLB 2859/4885GAA 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.